ProShares UltraShort NASDAQ Biotechnology
19 hedge funds and large institutions have $19.6M invested in ProShares UltraShort NASDAQ Biotechnology in 2015 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
1% less capital invested
Capital invested by funds: $19.9M → $19.6M (-$269K)
Holders
19
Holding in Top 10
1
Calls
$11.4M
Puts
$10.3M
Top Buyers
| 1 | +$1.92M | |
| 2 | +$919K | |
| 3 | +$738K | |
| 4 |
VF
Virtu Financial
New York
|
+$581K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$552K |
Top Sellers
| 1 | -$2.59M | |
| 2 | -$966K | |
| 3 | -$874K | |
| 4 |
Goldman Sachs
New York
|
-$214K |
| 5 |
FMA
FNY Managed Accounts
New York
|
-$138K |